EXELIXIS GROUP - Hon. Consulate of the Republic of Kenya ...trademission.kenyagreece.com/2013/files/2013/08/exelixis-group-pro… · EXELIXIS S.A. enters MDx & ART markets in GR,

EXELIXIS GROUP

Organization chart 2

Our product portfolio 3

Who are we 1

A closer look 4

Organization chart 2


Who are we 1

Our History Our Vision Our Strategy

A closer look 4

4

EXELIXIS S.A. established in Athens, Greece to serve the local public and private HC sector

Earns accreditation by the EU Quality System Certificate ISO 9001/2000 & ISO 13485

EXELIXIS S.A teams with major group of companies with various activities and annual turnaround of USD 25.00 Mio

EXELIXIS S.A. enters MDx & ART markets in GR, through exclusive agreements and establishes distribution points in SEE

EXELIXIS S.A. acquires Consumer Medicine Division formerly known as Gerolymatos OTC, and enters OTC & Rx markets

Rolls our Business Plan for business development in M. East – N. Africa

1993

2004

2000

2010

2013

2009

Who are we | Our History

Deliver True Value

Provide H/C professionals with Diagnostic and Medical solutions of established value, for the benefit of all patients, worldwide.

Clinical value

Pharmaceutical value

Financial Value

Innovation

Offer complete solutions that allow our commercial partners to use their full potential, grow their existing business and expand.

Produce pharmaceutical products and food supplements that deliver measurable results, allowing all consumers to live healthier lives.

Consistently deliver innovative Diagnostics and Pharmaceuticals that continuously drive diagnosis and clinical management forward.

Who are we | Our Vision

5

Continuously improve and innovate our VITAL® and other owned brands

Further strengthen our presence in SEE via improving current colla-borations

Launch new product lines to address OBGYN market

Expand to MENA markets via commercial partners

EXELIXIS Health & Care

Increase market pene-tration at the private H/C sector level

Launch complete solutions for infectious diseases & personalized healthcare

Build on successful product range for IVF and expand menu offer

Expand operations in MENA via partner-tailored solutions

EXELIXIS Diagnostics

Leverage existing OBGYN network to strengthen the Group’s global presence

Drive expansion of Future Health Stem Cell Banking into new geographical markets via commercial partners

Group affiliations

Turnkey solutions for accelerated growth & revenue streams, via Rx-Dx synergies, and a holistic approach to Marketing & Sales

Who are we | Our Strategy

Our three growth drivers:

6

Organization 2


Who are we 1

A closer look 4

Organization | EXELIXIS Group

8

Board of Directors

Managing Director

Commercial Director Marketing Director

Global Business

Development

Commercial Director Marketing Director

Quality Control Credit Control Legal IT Support


Organization 2

Who are we 1

A closer look 4

Our product portfolio | Products Overview

Complete Laboratory Automation

Molecular Diagnostics Portfolio

□ Infectious Diseases

□ Personalized Medicine

□ Cancer

□ STIs

Assisted Reproduction Solutions

□ DNA Fragmentation

□ Semen Analysis

□ IVF/ICSI Culture Media

Medical Devices

□ IVF Needles & Catheters

□ ICSI Micropipettes

□ Intrauterine contraceptives

Microbiology & Clinical Chemistry


Nutraceuticals

□ VITAL® plus Q10

□ VITAL plus Q10 Effervescent®

□ VITAL Silver®

□ VITAL Cardio®

□ VITAL Memo®

□ VITAL Cold®

□ Lacroflora®

Rx

□ ANTIS®

□ Saribal®

□ Lataneau®

Diabetes Monitoring

□ Infopia®


A global Stem Cell bank company

Present in 29 countries, with access to 35,000 obstetricians and gynecologists

Complete Stem Cell storage solution for families

□ Cord Blood cells

□ Cord Tissue cells

□ Tooth cells

□ Adipose tissue cells


Diagnostic & Med. devices Pharmaceutical Stem Cell BioBank

A closer look 4

Organization 2

Who are we 1

Our Dx solutions Our Pharma solutions Future Health BioBank


A closer look | Our Dx solutions

OB/GYN Fertility clinics Dx / Gx centers

Intrauterine insemination IUI preparation kit Consumables

Contraceptives (IUD) PROM detection Fertility evaluation

Sperm DNA fragment.

Complete ART solutions Oocyte retrieval IVF/ICSI procedures Embryo implantation

Fertility evaluation Sperm DNA fragment. Semen analysis

Laboratory automation Infectious diseases

Respiratory TPx

Cancer genetics Fertility evaluation

Sperm DNA fragment. Semen analysis

Ap

plic

atio

ns


Intrauterine Contraceptive Devices

Top-selling Contraceptives

High quality devices, manufactured in EU, individually packaged and sterilized

Indicated for intrauterine contraception

Copper-based, without hormonal additives

Recommended removal period of 5 years

IUD portfolio:

□ LOAD 375 – anchor-shaped, industry standard

□ UT 380 Standard | Short – T-shaped

□ TT 380 Standard | Mini – the single smallest IUD on the market , for nulliparous women

□ NT 380 Standard | Short – Silver-coated for copper intolerance

Come complete with packaging

Instructions for doctors and patients


Challenge Innovation Solution Markets

Couples with normal semen parameters (M), and hormonal profile (F) are unable to conceive naturally or through Assisted Reproduction. Cases referred to as “unex-plained infertility”.

Extensive R&D by Halotech DNA reveals that the degree of sperm DNA fragmen-tation plays a major role in the success rate of conception (either natural or assisted).

The Halosperm® assay allows for the easy, quick and accurate measurement of DNA fragmentation in semen. Halosperm® is now offered as a standard test in Dx and Fertility centers.

The Halosperm® solution is available for human semen evaluation in ART. In Veterinary semen testing, Halomax® is used to assess the reproductive capacity of breeding males.

Key Benefits: □ Disruptive innovation □ High Diagnostic value □ High Clinical value □ Entry point into IVF &

Veterinary markets


ICSI Micropipettes

Holding Injection Hatching Biopsy Denuding


Molecular Diagnostics Portfolio

Innovative multiplexing technology Broad CE-IVD portfolio

Respiratory infectious agents RespiFinder® SMART 22

Bacterial CNS infections MeningoFinder® SMART 7

Sexually transmitted infections STD-Finder® SMART 7

HPV typing PapillomaFinder® SMART 20

Established , reputable IVD solutions Broad RT-PCR Dx portfolio

STD virii Bacterial menengitis Complete Herpes panel Gastrointestinal infections Respiratory pathogens Controls A

pp

licat

ion

s

A closer look 4

Organization 2

Who are we 1



A closer look | Our Pharma solutions

Nutraceuticals

Pharmacy channel OTC (non-prescribable) Whole sales

Rx

Pharmacy channel OTC (non-prescribable) Whole sales

Prescribable

Pharmacy channel Prescribable medicines Whole sales

Food supplements Nutraceuticals Probiotic supplements

Antitussive syrups Mycolytic syrups Dermocosmetics Mouth ulcer treatment

Diabetes monitoring Anti-glaucoma eye drops

Mar

ket

acce

ss

Ap

plic

atio

ns

A closer look | The VITAL® brand

The VITAL® brand – Values

VITAL® plus Q10 VITAL® plus Q10 Effervescent

VITAL® Silver VITAL® Cardio

VITAL® Memo VITAL® Cold

Guaranteed effectiveness Selective combination of components and unique microelement formulations Key components

High concentration of Ginsenosides & Eleutherococcus senticoccus LipidCaps™ System Patented, innovative pharmaceutical-form capsule that conceals odours and prevents

gastric aggression, while simultaneously ensures optimal oral bioavailability Safe Products & Effective Formulas:

Quality ensured and regularly monitored by International accreditation bodies


The VITAL® brand – Main Consumer Categories

Individuals with demanding daily schedule Not balanced diet with frequent omission of vital dietary ingredients (e.g. fruits,

vegetables etc.) Increased need for antioxidants Athletes Bigger needs in nutritious components Need of protection from metabolic stress that cause the exercise Students Need for improvement of intellectual output and cope with stress People that feel the need to support and enhance their Immune System

Men and Women who experience stress, fatigue and lack vitality


The VITAL® brand – Special Consumer Categories

Vegetarians (usually deficient in Iron, Calcium, L-carnitine) Individuals under weight-loss diet Individuals facing medical conditions: Anorexia Hyperlipidemia (supplementary Co-enzyme Q10 is a requirement in antilipidemic

medication, also need of antioxidants) Diabetes type-2 (Documented lower levels of Co-enzyme Q10 in blood stream,

also elevated need for antioxidants due to oxidative stress ) Hypothyroidism (present lack of energy, and often under weight-loss diet )

Men & Women under strict diet and individuals with chronic health conditions


The VITAL® brand – Special Consumer Categories

Increased needs in antioxidant components Decreased endogenous production CoQ10 Decreased engagement of nutritious components because problems in feeding Increased needs in calcium and same vitamin D Decreased absorption of micronutrients components due to general

gastrointestine dysfunction Increased needs in micronutrients components due to frequent use of medicines Onset of degenerative disorders

Middle-aged and Elderly Men and Women

A closer look | The Lactoflora® brand

A brand new, unique dietary supplement featuring a combination of probiotics microorganisms that help restore and maintain a healthy flora of the intestine

Lactoflora® can be used adjunctively to antibiotic treatment

Lactoflora® – Product Overview

Posi

tio

nin

g

Available in box of 10 & 20 capsules

Key

In

gred

ien

ts

Pack

g.

A closer look | The Lataneau® brand

Latanoprost (prostagladin analogue) 0,005% w/v in eye-drop solution

Lataneau®

Act

ive

Ingr

edie

nt

Open Angle Glaucoma Raised pressure in the eye (ocular hypertension).

Ind

icat

ion

s

Lataneau lowers the pressure in the eye that results from fluid accumulation and can subsequently lead to Glaucoma

Glaucoma affects ca. 12 Mio people in Europe alone and is the most common cause of blindness D

escr

ipti

on

Non-Productive

Cough

Productive

A closer look | Anti-cough drugs

Butamirate citrate 7,5mg / 5ml A

ctiv

e In

gred

ien

t

Sugar-free It has a pleasant vanilla flavor It does not have serious side effects Fe

atu

res

Ambroxol Hydrochloride 30mg / 5ml

Sugar-free It has a pleasant mint flavor It does not have serious side effects

25

26

A closer look | Our complete Pharma portfolio

A closer look 4

Organization 2

Who are we 1



A closer look| Future Health BioBank

Future Health BioBank

The first private family cord blood bank to receive a full accreditation as a human tissue bank by the MHRA UK

Own purpose built laboratories in the UK & Switzerland

Accredited by

□ MHRA (Medicines & Healthcare products Regulatory Agency)

□ HTA (Human Tissue Bank)

□ MHRA BEA (Blood Establishment Authorization)

□ cGMP / ISO / GLP

Winner of The Queen’s Award for Enterprise 2010

Offers the broadest range solutions for stem cell storage

Parents receive Collection kit

Parents bring Collection kit to labour ward on

labour day

Labour ward staff collect and store cord blood cell sample in

Collection kit

Collection kit is shipped to Future

Health BioBank

Future Health BioBank scientific

team isolates stem cells

Stem cells stored by Future Health

Biobank for 25 years

Thank you!

29

Documents

EXELIXIS GROUP - Hon. Consulate of the Republic of Kenya ...trademission.kenyagreece.com/2013/files/2013/08/exelixis-group-pro… · EXELIXIS S.A. enters MDx & ART markets in GR,